An overview of MOTS-c, its discovery, mechanism, and role in modern metabolic and aging research.
For most of modern biology, mitochondria have been studied as the cell’s energy factories — organelles that take in substrates and produce ATP. That framing is changing fast. Over the last decade, researchers have identified a class of peptides encoded directly within mitochondrial DNA that appear to act as regulatory signaling molecules in their own right. MOTS-c is the most well-known member of this group, and the research surrounding it has opened an entirely new conversation about how mitochondria communicate with the rest of the cell.
What Is MOTS-c?
MOTS-c stands for Mitochondrial Open Reading Frame of the Twelve S rRNA type-c. It is a 16-amino-acid peptide encoded in a small open reading frame within the 12S ribosomal RNA region of mitochondrial DNA. Its discovery in 2015 by Changhan Lee, Pinchas Cohen, and colleagues at the University of Southern California was notable for several reasons: it confirmed that mitochondria encode active signaling peptides, it introduced the concept of “mitochondrial-derived peptides” (MDPs), and it provided a potential new link between mitochondrial function and whole-body metabolism.
Unlike peptides synthesized in the cytoplasm based on nuclear DNA, MOTS-c originates inside the mitochondrion itself. Under metabolic stress, research indicates it translocates to the nucleus where it can influence gene expression — a striking example of organelle-to-nucleus communication.
Mechanism of Action
The research around MOTS-c points to several interrelated mechanisms:
- AMPK activation. Studies have shown that MOTS-c activates AMP-activated protein kinase (AMPK), the cellular energy sensor that regulates glucose uptake, fatty acid oxidation, and mitochondrial biogenesis.
- Glucose and insulin signaling. In cell and animal models, MOTS-c has been associated with improved insulin sensitivity and enhanced skeletal muscle glucose uptake, even without exercise stimulation.
- Nuclear gene regulation. One of the more surprising findings is that MOTS-c translocates to the nucleus during metabolic stress, where it influences antioxidant response genes and metabolic pathways. This places it among the few peptides capable of retrograde mitochondrial-to-nuclear signaling.
- Exercise mimicry. Research suggests MOTS-c shares overlapping pathways with exercise-induced signaling, leading some groups to describe it as an “exercise mimetic” in preclinical work.
- Metabolic–inflammatory crosstalk. Because metabolic dysfunction and chronic inflammation are tightly linked, MOTS-c’s ability to restore metabolic efficiency has also been associated with reduced inflammatory signaling in research models.
Research Highlights
Several lines of research have helped put MOTS-c on the map:
- Metabolic disease models. In the original Cell Metabolism paper, administration of MOTS-c improved insulin sensitivity in diet-induced obese mice and attenuated age-dependent insulin resistance.
- Exercise biology. Published studies have shown that circulating MOTS-c levels respond to exercise, and that MOTS-c administration has been reported to improve exercise capacity and physical performance in aged mice. This has made MOTS-c an area of interest in sports science and aging research.
- Longevity and aging. Because mitochondrial dysfunction is considered a hallmark of aging, research groups have explored whether MOTS-c acts as a longevity-associated signaling molecule. Circulating MOTS-c levels decline with age, and studies in rodents have examined whether restoring those levels influences markers of age-related decline.
- Cardiometabolic research. MOTS-c has been investigated in models of cardiovascular stress, hepatic steatosis, and metabolic syndrome, with the research focus on restoring metabolic flexibility rather than targeting a single pathway.
Areas of Ongoing Investigation
MOTS-c is still early in its research arc, and several directions remain under active study:
- Its role as a potential biomarker of mitochondrial health across the lifespan.
- Interactions with other mitochondrial-derived peptides such as humanin and the SHLPs.
- Its behavior in humans during exercise, fasting, and metabolic challenge.
- Structure-activity research aimed at developing analogs with improved stability and pharmacokinetics.
Research Considerations
Researchers working with MOTS-c typically keep a few points in mind:
- Stability. Like many short peptides, MOTS-c benefits from careful reconstitution and cold storage to preserve integrity during experimental work.
- Species differences. Much of the published data is from rodent models. Human physiology and human MOTS-c dynamics are still being characterized.
- Pathway overlap. Because MOTS-c influences AMPK and related sensors, research designs often need to account for confounding effects from diet, fasting, and exercise conditions in experimental animals.
Closing Thoughts
MOTS-c represents a conceptual shift in how researchers think about mitochondria — not just as passive energy producers, but as active signaling hubs with their own encoded messengers. The peptide is still in the early phase of its research arc, but the volume of published work is growing quickly, and the questions it raises about metabolic regulation, aging, and exercise biology are some of the most interesting in modern physiology.
